All Stories

  1. APOE in subjective cognitive decline: a systematic review and meta-analysis
  2. A scoping review about the efficacy of clonazepam for the treatment of benign essential blepharospasm
  3. Diagnosis and management of subjects with mild cognitive impairment in clinical practice: an Italian delphi consensus study
  4. The Use of Non-Invasive Brain Stimulation Techniques in Subjects with Parkinson’s Disease and Mild Cognitive Impairment: A Systematic Review
  5. Promising biomarkers for mild cognitive impairment and Alzheimer’s disease: Levels of soluble endothelial glycocalyx products
  6. Transcranial Random Noise Stimulation over the Dorsolateral Prefrontal Cortex in Patients with Parkinson’s Disease and Mild Cognitive Impairment: A Pilot Study
  7. Rituximab in stiff-person syndrome with glutamic acid decarboxylase 65 autoantibody: a systematic review
  8. TREM 2 in Parkinson’s Disease: A Promising Candidate Gene for Disease Susceptibility and Progression
  9. Telecoaching and Migraine: Digital Approach to Physical Activity in Migraine Management. A Scoping Review
  10. The Impact of COVID-19 on Migraine: The Patients’ Perspective
  11. Syndecans in Alzheimer’s disease: pathogenetic mechanisms and potential therapeutic targets
  12. Effectiveness and Safety of Mycophenolate Mophetil in Myasthenia Gravis: A Real-Life Multicenter Experience
  13. Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?
  14. Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?
  15. Persistent Cognitive Dysfunction in a Non-Hospitalized COVID-19 Long-Hauler Patient Responding to Cognitive Rehabilitation and Citicoline Treatment
  16. Sex and gender differences in Alzheimer’s disease, Parkinson’s disease, and Amyotrophic Lateral Sclerosis: A narrative review
  17. New-onset headache following COVID-19: An Italian multicentre case series
  18. Internal carotid artery dissection in a patient with hemophilia A: a case report and literature review
  19. Frequency and Correlates of Mild Cognitive Impairment in Myasthenia Gravis
  20. Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis
  21. Sound-Induced Flash Illusions Support Cortex Hyperexcitability in Fibromyalgia
  22. From Small Peptides to Large Proteins against Alzheimer’sDisease
  23. Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis
  24. Hands–feet wireless devices: Test–retest reliability and discriminant validity of motor measures in Parkinson's disease telemonitoring
  25. Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabút Aging Project
  26. Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabùt Aging Project
  27. Executive functioning and serum lipid fractions in Parkinson’s disease—a possible sex-effect: the PACOS study
  28. Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
  29. Cognitive impairment and levodopa induced dyskinesia in Parkinson’s disease: a longitudinal study from the PACOS cohort
  30. Transcranial random noise stimulation over the primary motor cortex in PD-MCI patients: a crossover, randomized, sham-controlled study
  31. Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study
  32. Serum alkaline phosphatase is elevated and inversely correlated with cognitive functions in subjective cognitive decline: results from the ReGAl 2.0 project
  33. Cardiovascular autonomic function and MCI in Parkinson's disease
  34. Electrocortical networks in Parkinson's disease patients with Mild Cognitive Impairment. The PaCoS study
  35. Objective assessment of blinking and facial expressions in Parkinson’s disease using a vertical electro-oculogram and facial surface electromyography
  36. Visuospatial learning is fostered in migraine: evidence by a neuropsychological study
  37. Mild Behavioral Impairment in Parkinson’s Disease: Data from the Parkinson’s Disease Cognitive Impairment Study (PACOS)
  38. Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
  39. Comment on “Sleep disturbances and later cognitive status: a multi-centre study”
  40. The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI)
  41. Frequency and Correlates of Subjective Memory Complaints in Parkinson’s Disease with and without Mild Cognitive Impairment: Data from the Parkinson’s Disease Cognitive Impairment Study
  42. Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)
  43. Dietary Supplements as Surrogate of Mediterranean Diet in Healthy Smoking Subjects
  44. Ageing: from inflammation to cancer
  45. Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred
  46. The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design
  47. β-glucans: ex vivo inflammatory and oxidative stress results after pasta intake
  48. FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease
  49. Isolated, subtle, neurological abnormalities in neurologically and cognitively healthy aging subjects
  50. Double Negative (IgG+IgD−CD27−) B Cells are Increased in a Cohort of Moderate-Severe Alzheimer's Disease Patients and Show a Pro-Inflammatory Trafficking Receptor Phenotype
  51. Lymphocytic Mitochondrial Aconitase Activity is Reduced in Alzheimer's Disease and Mild Cognitive Impairment
  52. Alzheimer’s disease and infections, where we stand and where we go
  53. Double negative (CD19+IgG+IgD−CD27−) B lymphocytes: A new insight from telomerase in healthy elderly, in centenarian offspring and in Alzheimer's disease patients
  54. SHIP2: A “NEW” Insulin Pathway Target for Aging Research
  55. The neuropsychiatric profile of Parkinson’s disease subjects with and without mild cognitive impairment
  56. Can Alzheimer Disease Be a Form of Type 3 Diabetes?
  57. Mediterranean Diet and Longevity in Sicily: Survey in a Sicani Mountains Population
  58. Prevalence and Profile of Mild Cognitive Impairment in Parkinson’s Disease
  59. Blood group does not appear to affect longevity a pilot study in centenarians from Western Sicily
  60. The symptom of low mood in the prodromal stage of mild cognitive impairment and dementia: a cohort study of a community dwelling elderly population
  61. Validation Study of the Italian Addenbrooke’s Cognitive Examination Revised in a Young-Old and Old-Old Population
  62. Cognitive Performance in Elderly Patients Undergoing Carotid Endarterectomy or Carotid Artery Stenting: A Twelve-Month Follow-Up Study
  63. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment
  64. A Systematic Review of Neuropsychiatric Symptoms in Mild Cognitive Impairment
  65. Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types
  66. Association between plasma lipid levels and migraine in subjects aged ≥50 years: preliminary data from the Zabùt Aging Project
  67. Comorbidity between depressive symptoms and migraine: preliminary data from the Zabút Aging Project
  68. Occurrence of cognitive impairment and dementia in the community: A 9-year-long prospective study
  69. Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: Two case reports
  70. Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project
  71. Migraine Mediates the Influence of C677T MTHFR Genotypes on Ischemic Stroke Risk With a Stroke-Subtype Effect
  72. Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease
  73. Interictal Executive Dysfunction in Migraineurs Without Aura: Relationship With Duration and Intensity of Attacks
  74. Predictors of progression from mild cognitive impairment to Alzheimer disease
  75. Heterogeneity in Risk Factors for Cognitive Impairment, No Dementia: Population-Based Longitudinal Study From the Kungsholmen Project
  76. Vascular Risk Factors in Mild Cognitive Impairment Subtypes
  77. Prognosis of migraine headaches in adolescents: A 10-year follow-up study
  78. Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases
  79. Association between apolipoprotein E e4 allele and apathy in probable Alzheimer's disease.
  80. Erratum
  81. Effects of levodopa oral bolus on the kinematics of the pointing movements in Parkinson’s disease patients
  82. Cognitive impairment in Behçet's disease patients without overt neurological involvement
  83. The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction
  84. Corrigendum to “Effects of 8-OH-DPAT on open field performance of young and aged rats prenatally exposed to diazepam: a tool to reveal 5-HT1A receptor function”
  85. [3H]-DA release evoked by low pH medium and internal H+ accumulation in rat hypothalamic synaptosomes: involvement of calcium ions
  86. Effects of 8-OH-DPAT on open field performance of young and aged rats prenatally exposed to diazepam: a tool to reveal 5-HT1A receptor function
  87. No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease
  88. Prevalence of headache in patients with Behcet's disease without overt neurological involvement
  89. Enalapril Prophylaxis for Migraine With Aura
  90. Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease
  91. Migraine Headaches in Adolescents: A Five-Year Follow-Up Study
  92. Red Ear Syndrome and Migraine: Report of Eight Cases
  93. Erythematous maculopapular eruption due to rivastigmine therapy
  94. Intracerebral haemorrhage associated with sildenafil citrate
  95. Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations
  96. Cognitive deficits in beta-thalassemia major